These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 33801478)

  • 21. Prostate cancer induced bone pain: pathobiology, current treatments and pain responses from recent clinical trials.
    Smith AE; Muralidharan A; Smith MT
    Discov Oncol; 2022 Oct; 13(1):108. PubMed ID: 36258057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Management of Cancer Symptoms and Treatment-Induced Side Effects With Cannabis or Cannabinoids.
    Sexton M; Garcia JM; Jatoi A; Clark CS; Wallace MS
    J Natl Cancer Inst Monogr; 2021 Nov; 2021(58):86-98. PubMed ID: 34850897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treating breakthrough pain in oncology.
    Mercadante S
    Expert Rev Anticancer Ther; 2018 May; 18(5):445-449. PubMed ID: 29478355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fentanyl buccal tablet.
    Messina J; Darwish M; Fine PG
    Drugs Today (Barc); 2008 Jan; 44(1):41-54. PubMed ID: 18301803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Prevalence and Characteristics of Breakthrough Cancer Pain in Patients Receiving Low Doses of Opioids for Background Pain.
    Mercadante S; Maltoni M; Russo D; Adile C; Ferrera P; Rossi R; Rosati M; Casuccio A
    Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33801478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Longitudinal Study of Breakthrough Cancer Pain: An Extension of IOPS-MS Study.
    Mercadante S; Caraceni A; Cuomo A; Mammucari M; Marchetti P; Mediati RD; Natoli S; Tonini G
    J Clin Med; 2021 May; 10(11):. PubMed ID: 34073907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breakthrough Cancer Pain in Patients With Abdominal Visceral Cancer Pain.
    Mercadante S; Adile C; Masedu F; Valenti M; Aielli F
    J Pain Symptom Manage; 2019 May; 57(5):966-970. PubMed ID: 30822530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breakthrough Pain in Patients with Lung Cancer. A Secondary Analysis of IOPS MS Study.
    Mercadante S; Masedu F; Valenti M; Aielli F
    J Clin Med; 2020 May; 9(5):. PubMed ID: 32375331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breakthrough pain in patients with head & neck cancer. A secondary analysis of IOPS MS study.
    Mercadante S; Masedu F; Valenti M; Aielli F
    Oral Oncol; 2019 Aug; 95():87-90. PubMed ID: 31345399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Understanding the Chameleonic Breakthrough Cancer Pain.
    Mercadante S; Portenoy RK
    Drugs; 2021 Mar; 81(4):411-418. PubMed ID: 33515376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Episodic Cancer Pain: Patient Reporting, Prevalence, and Clinicodemographic Associations at Initial Cancer Pain Clinic Assessment.
    Reis-Pina P; Acharya A; Barbosa A; Lawlor PG
    Pain Res Manag; 2020; 2020():6190862. PubMed ID: 32566062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, double-blind, crossover, dose ranging study to determine the optimal dose of oral opioid to treat breakthrough pain for patients with advanced cancer already established on regular opioids.
    Currow DC; Clark K; Louw S; Fazekas B; Greene A; Sanderson CR
    Eur J Pain; 2020 May; 24(5):983-991. PubMed ID: 32060972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breakthrough Cancer Pain in Patients Receiving Low Doses of Opioids for Background Pain.
    Mercadante S; Caraceni A; Masedu F; Scipioni T; Aielli F
    Oncologist; 2020 Feb; 25(2):156-160. PubMed ID: 31862860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and characterization of breakthrough pain in patients with cancer in Spain: the CARPE-DIO study.
    Pérez-Hernández C; Blasco A; Gándara Á; Mañas A; Rodríguez-López MJ; Martínez V; Fernandez-Nistal A; Montoto C
    Sci Rep; 2019 Nov; 9(1):17701. PubMed ID: 31776408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of rapid onset fentanyl products in the management of breakthrough pain in cancer patients.
    Brząkała J; Leppert W
    Pharmacol Rep; 2019 Jun; 71(3):438-442. PubMed ID: 31003154
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.